ABSTRACT
Understanding and skills in psychotherapy are fundamental aspects of clinical psychiatry practice. Learning about psychotherapy during the training of psychiatrists offers solid opportunities for developing high standards of psychiatric practice and providing better outcomes for patients. However, little is known about the extent that psychotherapy training is available to psychiatrists in America. This study aimed to analyze the status of psychotherapy training in Brazil through the experiences of early-career psychiatrists. This is a cross-sectional survey conducted between July and November 2021. A 16-item questionnaire was used to investigate: the quality of psychotherapy training; the organizational aspects of psychotherapy training; and satisfaction with training in psychotherapy. The majority of participants reported having mandatory training in psychotherapy, mainly in cognitive-behavioral therapy and psychodynamic therapy. However, only had some practical experience with psychotherapy training. This study highlights the frequent use of psychotherapy training among Brazilian early career psychiatrists. The consensus on the necessity of mandatory psychotherapy training underscores its importance in shaping psychiatric practice. While participants express satisfaction with psychotherapy supervision, the financial burden for advanced training raises concerns. These findings advocate for the improvement of the quality of psychotherapy training in Brazil.
Subject(s)
Cognitive Behavioral Therapy , Psychiatrists , Humans , Brazil , Cross-Sectional Studies , Psychotherapy , Cognitive Behavioral Therapy/educationABSTRACT
OBJECTIVE: The aim of this study was to translate the Structured Clinical Interview for Mood Spectrum into Brazilian Portuguese, measuring its reliability, validity, and defining scores for bipolar disorders. METHOD: Questionnaire was translated (into Brazilian Portuguese) and back-translated into English. Sample consisted of 47 subjects with bipolar disorder, 47 with major depressive disorder, 18 with schizophrenia and 22 controls. Inter-rater reliability was tested in 20 subjects with bipolar disorder and MDD. Internal consistency was measured using the Kuder Richardson formula. Forward stepwise discriminant analysis was performed. Scores were compared between groups; manic (M), depressive (D) and total (T) threshold scores were calculated through receiver operating characteristic (ROC) curves. RESULTS: Kuder Richardson coefficients were between 0.86 and 0.94. Intraclass correlation coefficient was 0.96 (CI 95 % 0.93-0.97). Subjects with bipolar disorder had higher M and T, and similar D scores, when compared to major depressive disorder (ANOVA, p < 0.001). The sub-domains that best discriminated unipolar and bipolar subjects were manic energy and manic mood. M had the best area under the curve (0.909), and values of M equal to or greater than 30 yielded 91.5% sensitivity and 74.5% specificity. CONCLUSION: Structured Clinical Interview for Mood Spectrum has good reliability and validity. Cut-off of 30 best differentiates subjects with bipolar disorder vs. unipolar depression. A cutoff score of 30 or higher in the mania sub-domain is appropriate to help make a distinction between subjects with bipolar disorder and those with unipolar depression.
Subject(s)
Bipolar Disorder/diagnosis , Depressive Disorder, Major/diagnosis , Interview, Psychological , Schizophrenia/diagnosis , Surveys and Questionnaires , Translating , Adult , Brazil , Humans , Language , Male , Middle Aged , Reproducibility of Results , Sensitivity and Specificity , Young AdultABSTRACT
OBJECTIVE: The aim of this study was to translate the Structured Clinical Interview for Mood Spectrum into Brazilian Portuguese, measuring its reliability, validity, and defining scores for bipolar disorders. METHOD: Questionnaire was translated (into Brazilian Portuguese) and back-translated into English. Sample consisted of 47 subjects with bipolar disorder, 47 with major depressive disorder, 18 with schizophrenia and 22 controls. Inter-rater reliability was tested in 20 subjects with bipolar disorder and MDD. Internal consistency was measured using the Kuder Richardson formula. Forward stepwise discriminant analysis was performed. Scores were compared between groups; manic (M), depressive (D) and total (T) threshold scores were calculated through receiver operating characteristic (ROC) curves. RESULTS: Kuder Richardson coefficients were between 0.86 and 0.94. Intraclass correlation coefficient was 0.96 (CI 95 percent 0.93-0.97). Subjects with bipolar disorder had higher M and T, and similar D scores, when compared to major depressive disorder (ANOVA, p < 0.001). The sub-domains that best discriminated unipolar and bipolar subjects were manic energy and manic mood. M had the best area under the curve (0.909), and values of M equal to or greater than 30 yielded 91.5 percent sensitivity and 74.5 percent specificity. CONCLUSION: Structured Clinical Interview for Mood Spectrum has good reliability and validity. Cut-off of 30 best differentiates subjects with bipolar disorder vs. unipolar depression. A cutoff score of 30 or higher in the mania sub-domain is appropriate to help make a distinction between subjects with bipolar disorder and those with unipolar depression.
OBJETIVO: Traduzir e validar para o português a Entrevista Clínica Estruturada para Distúrbios do Humor, mensurando sua validade, confiabilidade, bem como definindo os escores para transtornos bipolares. MÉTODO: A entrevista foi traduzida (para o português) e novamente traduzida para o inglês. A amostra incluiu 47 indivíduos com transtornos bipolares, 47 com transtorno depressivo maior, 18 com esquizofrenia e 22 controles. A confiabilidade entre avaliadores foi testada em 20 indivíduos com transtornos bipolares e transtorno depressivo maior. A consistência interna foi mensurada por meio da fórmula de Kuder Richardson. Análise discriminante foi realizada. Escores dos diversos grupos foram comparados; limiares para mania (M), depressão (D) e valores totais foram calculados usando curvas de "receiver operating characteristic" (ROC). RESULTADOS: Coeficientes de Kuder Richardson ficaram entre 0,86 e 0,94. O coeficiente de correlação intraclasse foi de 0,96 (IC 95 por cento 0,93-0,97). Participantes com transtornos bipolares apresentaram escores M e T aumentados, e escores D semelhantes aos do grupo transtorno depressivo maior (ANOVA, p < 0,001). Os subdomínios que melhor discriminaram indivíduos com doença uni ou bipolar foram energia maníaca e humor maníaco. M apresentou a melhor área sob a curva (0,909); valores de M igual ou superiores a 30 associaram-se a sensibilidade de 91,5 por cento e especificidade de 74,5 por cento. CONCLUSÃO: Entrevista Clínica Estruturada para Distúrbios do Humor apresenta boa validade e reliabilidade. Escore de mania igual ou superior a 30 adequadamente diferencia transtornos bipolares de depressão unipolar.
Subject(s)
Adult , Humans , Male , Middle Aged , Young Adult , Bipolar Disorder/diagnosis , Depressive Disorder, Major/diagnosis , Interview, Psychological , Surveys and Questionnaires , Schizophrenia/diagnosis , Translating , Brazil , Language , Reproducibility of Results , Sensitivity and SpecificityABSTRACT
O objetivo deste estudo é desenvolver uma versão em português, a SCI-MOODS - VP (Entrevista Clínica Estruturada para o Espectro do Humor), determinando sua confiabilidade e validade. A SCI-MOODS foi traduzida para o português e retro-traduzida. Foram selecionados bipolares (n=47), unipolares (n=47), esquizofrênicos (n=18), e normais (n=22), A consistência interna variou entre 0.86 to 0.94. A correlação intraclasse foi 0,956. Os bipolares apresentaram escores total e maníaco da SCI-MOODS - VP maiores que os outros grupos. A energia maníaca e o humor maníaco foram os sub domínios que melhor distinguiram os bipolares de unipolares através de uma análise discriminante. A SCI-MOODS - VP apresentou boa validade discriminante e confiabilidade.
A Brazilian Portuguese version of Structured Clinical Interview for Mood Spectrum (SCI-MOODS-VP) was developed and its reliability and validity established. SCI-MOODS was translated to Portuguese and back-translated. Bipolars (n=47), unipolars (n=47), Schizophrenics (n=18), normal subjects (n=22) were selected. The internal consistency was 0, 86 to 0, 94 and intraclass coefficient 0,956. The bipolar subjects had total and manic scores higher than other groups. The manic energy and mood were the sub domains that best distinguished bipolar and unipolar subjects by discriminant analysis. SCI-MOODS-VP has good reliability and discriminant validity.
Subject(s)
Reproducibility of Results , Bipolar Disorder/diagnosis , Validation Study , Mental Status ScheduleABSTRACT
Pelo menos 5 por cento (Moreno, 2004 e Angst et al., 2003) da população geral já apresentou mania ou hipomania. A irritabilidade e sintomas depressivos durante episódios de hiperatividade breves e a heterogeneidade de sintomas complicam o diagnóstico. Doenças neurológicas, endócrinas, metabólicas e inflamatórias podem causar uma síndrome maníaca. As vezes, a hipomania ou a mania são diagnosticadas de forma errada como normalidade, depressão maior, esquizofrenia ou transtornos de personalidade, ansiosos ou de controle de impulsos. O lítio é a primeira escolha no tratamento da mania, mas ácido valpróico, carbamazepina e antipsicóticos atípicos são também freqüentemente utilizados. A eletroconvulsoterapia está indicada na mania grave, psicótica ou gestacional. A maioria dos estudos controlados para a profilaxia de episódios maníacos foi realizada com lítio e mais estudos são necessários para investigar a eficácia profilática do valproato, da olanzapina e de outras medicações. O tratamento e a profilaxia da hipomania foram pouco estudados e, de modo geral, seguem as mesmas diretrizes usadas para a mania.
Subject(s)
Humans , Bipolar Disorder/diagnosis , Bipolar Disorder/prevention & control , Bipolar Disorder/therapyABSTRACT
Bipolar disorder is a complex medical condition, and up to the date there is no single treatment with proven efficacy in the control of all aspects of the illness. The available literature on the use of anticonvulsants (valproate, carbamazepine, oxcarbazepine, lamotrigine, gabapentin, topiramate, clonazepam) and atypical antipsychotics (clozapine, risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole) for acute and prophylactic treatment of bipolar disorder was reviewed. There is a large amount of evidence that lithium is efficacious in the prophylaxis of episodes and better for acute mania than for depressive episodes. Other data show that carbamazepine and valproate are effective in acute manic episodes. Lamotrigine has been shown to reduce cycling and effective in depressive episodes. Based on the available data, olanzapine was found to be the most appropriate atypical antipsychotic agent for the treatment of manic bipolar patients, although there are also studies suggesting the efficacy of risperidone, aripiprazole and clozapine. The preliminary data evaluating the efficacy of quetiapine and ziprasidone in bipolar disorder are still very limited. There is no consistent information supporting the prophylactic use of newer antipsychotics.
Subject(s)
Anticonvulsants/therapeutic use , Antipsychotic Agents/therapeutic use , Bipolar Disorder/drug therapy , Acute Disease , Drug Therapy, Combination , Evidence-Based Medicine , HumansABSTRACT
O transtorno bipolar é uma condição médica complexa e até o momento não há um tratamento único comprovadamente eficaz no controle de todos aspectos da doença. Foram revisadas a literatura disponível sobre o uso de anticonvulsivantes (valproato, carbamazepina, oxcarbazepina, lamotrigina, gabapentina, topiramato, clonazepam) e antipsicóticos atípicos (clozapina, risperidona, olanzapina, quetiapina, ziprasidona e aripiprazole) no tratamento agudo e profilático do transtorno bipolar. Existe um acúmulo de evidências acerca da eficácia do lítio na profilaxia e de ser melhor no tratamento da mania aguda do que nos episódios depressivos. Outros dados indicam que a carbamazepina e o valproato são eficazes na mania aguda. A lamotrigina parece reduzir ciclagem e ser eficaz em episódios depressivos. Baseado nas informações disponíveis, as evidências apontam a olanzapina como o antipsicótico atípico mais apropriado no tratamento de pacientes bipolares em mania, embora existam estudos sugerindo a eficácia da risperidona, aripiprazol e da clozapina. Resultados preliminares avaliando a eficácia de ziprasidona e quetiapina no transtorno bipolar ainda são bastante limitadas. Não há dados consistentes apoiando o uso profilático dos novos antipsicóticos.
